Merck Millipore participates in Peking University programme
Merck Millipore has announced that it has been invited to serve on the faculty of the Centre for Pharmaceutical Information and Engineering Research (CPIER) at Peking University, China.
Merck Millipore has announced that it has been invited to serve on the faculty of the Centre for Pharmaceutical Information and Engineering Research (CPIER) at Peking University, China.
They will collaborate with the university to advance the training of pharmaceutical development, manufacturing and regulatory professionals in China. Established in 2006, the course relies on industry partners to help to prepare master’s candidates in its international pharmaceutical engineering programme. Merck Millipore will teach a module on quality and production processes, focusing specifically on sterilizing filtration, aseptic processing and critical filter validation.
Jean-Paul Mangeolle, head of Merck Millipore’s Process Solutions business, said, “It’s a privilege for Merck Millipore to collaborate with top pharmaceutical companies and regulators in delivering a curriculum to advance industry best practices in China. Our expertise will help ensure that education focuses on the quality and safety of products – made and consumed locally – in the years to come.”
For more information please visit ref="http://www.merckmillipore.com">www.merckmillipore.com
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
